From Michael Dunn’s acquittal in the murder of Jordan Davis to a pending nominee to the federal bench, now more than ever our courts matter.
It was reported recently that French drug manufacturer HRA Pharma had found that the emergency contraceptive Norlevo, which has a similar chemical makeup to Plan B One-Step, is ineffective for women over 176 pounds. Here’s why I was not surprised.
The recent news about emergency contraception’s efficacy in women who weigh over 176 pounds shows how badly the media can screw up stories about weight and health. Here are some tips for writing about this issue in a way that is less shaming and more accurate.
Right to Life of Michigan’s federal lawsuit adds to a pile of recent court cases challenging whether corporations can refuse to provide employees contraception coverage in employer-sponsored health insurance plans on moral grounds.
The shame and stigma around emergency contraception, and all reproductive health care for that matter, all too often deter those who need reproductive care the most from accessing it.
Why would the Obama administration support such restrictions, which not only put the health and lives of young women at risk, but also further disable young women from taking control of our sexuality?
The Second Circuit Court of appeals denied in part the Obama administration’s request that an earlier ruling to make emergency contraception widely available be put on hold.
Continuing to fight science and common sense on Plan B isn’t serving anyone’s interests. Pro-choicers are mad, anti-choicers aren’t placated, and women are hurt in the process. So why does the Obama administration insist on keeping up this pointless fight?
The debate is characterized by anti-abortion anxiety and aversion to subsidized contraception.
U.S. District Court Judge Edward R. Korman today delivered a scorching critique of the Obama administration’s policies, saying that the FDA’s decision-making on EC has been corrupted by political influence.